Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $50.83 Consensus PT from Analysts
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]
More Stories
Barclays Boosts Canadian Pacific Kansas City (NYSE:CP) Price Target to $97.00
Canadian Pacific Kansas City (NYSE:CP – Free Report) (TSE:CP) had its price target hoisted by Barclays from $95.00 to $97.00...
Ocugen (NASDAQ:OCGN) and BioNTech (NASDAQ:BNTX) Head-To-Head Analysis
BioNTech (NASDAQ:BNTX – Get Free Report) and Ocugen (NASDAQ:OCGN – Get Free Report) are both medical companies, but which is...
Harleysville Financial (OTCMKTS:HARL) versus Burke & Herbert Financial Services (NASDAQ:BHRB) Critical Contrast
Burke & Herbert Financial Services (NASDAQ:BHRB – Get Free Report) and Harleysville Financial (OTCMKTS:HARL – Get Free Report) are both...
Financial Analysis: Terna (OTCMKTS:TERRF) and Eversource Energy (NYSE:ES)
Eversource Energy (NYSE:ES – Get Free Report) and Terna (OTCMKTS:TERRF – Get Free Report) are both utilities companies, but which...
Ultrapetrol (Bahamas) (OTCMKTS:ULTRF) & Performance Shipping (NASDAQ:PSHG) Financial Survey
Performance Shipping (NASDAQ:PSHG – Get Free Report) and Ultrapetrol (Bahamas) (OTCMKTS:ULTRF – Get Free Report) are both transportation companies, but...
B&G Foods (NYSE:BGS) Lifted to Hold at StockNews.com
StockNews.com upgraded shares of B&G Foods (NYSE:BGS – Free Report) from a sell rating to a hold rating in a...